Here's Wouldn't Touch Moderna: Why I Won't Bet on Its Next Growth Engine
Moderna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
Compare safety profiles of hot versus cold wallets and learn best practices to keep your funds secure in daily use.
20,484 articlesModerna surged on pandemic-era demand. But what comes next? This piece examines why some investors are wary, what a t...
As stocks climb, a warning from the former chair of the Federal Reserve signals risk ahead. This guide explains the t...
February market action favors growth names as earnings beat and cash flow strengthens. This report highlights three h...
A surge in Palo Alto Networks stock in May grabbed headlines, but a reverse move in June left investors weighing the ...
This article breaks down everquote (ever) 2025 earnings with a clear, investor-focused lens. Learn the key metrics to...
SoFi’s five-year arc has been a brutal test of conviction: a steep drawdown followed by a rebound as the fintech seek...
ONEOK posted robust Q4 2025 results, boosting full-year EBITDA, trimming debt, and highlighting synergies from recent...
Stocks pull back as policy tensions between the White House and the Fed intensify, ending a stretch of optimism and s...
DigitalOcean beats Q4 2025 expectations as AI-driven ARR surges to $120 million, lifting revenue to $242 million and ...
Schg’s 32× start melt-up is shaping a pivotal market moment: can a growth-heavy ETF sustain gains on high valuations,...
A high-conviction AI bet is reshaping how Ackman runs his hedge fund. Learn why nearly 40% of his capital sits in thr...
Eli Lilly is shaking up its growth plan by expanding beyond obesity with new infectious disease initiatives. This art...